Descrizione business
The biopharmaceutical company co.don AG based near Berlin is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects. The company's patented pharmaceutical products are used to treat cartilage damage. Left untreated, cartilage defects can often result in joint replacement surgery.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| - |
| Consiglio di amministrazione |
| Dr. Achim Simons, Tilmann Bur |
| Consiglio di sorveglianza |
| Prof. Hans B. Bauerfeind, Thommy Stählin, Beatrix Bauerfeind-Johnson, Prof. Dr. Barbara Sickmüller, Prof. Dr. Hans-Jörg Bullinger, Thomas Krause |
Dati aziendali
| Name: |
Co.don AG |
| Indirizzo: |
Warthestraße 21,D-14513 Teltow |
| Telefono: |
+49-3328-4346-0 |
| Fax: |
+49-3328-4346-43 |
| E-mail: |
info@codon.de
|
| Internet: |
www.codon.de |
| Industria: |
Biotechnology |
| Settore: |
Biotechnology |
| Sub settore: |
Biotechnology |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
41.56% |
| Data dell'IPO: |
14/02/2001 |
Rapporti con gli investitori
| Name: |
Matthias Meißner |
| IR telefono: |
49-30-2403-52-330 |
| IR Fax: |
- |
| IR e-mail: |
ir@codon.de
|
